Why APIs Fail At Scale: It’s Not The Molecule, It’s The Route

In chemical process development, route scouting in API development is far more than a preliminary step—it is a strategic foundation that can determine the success of bringing an active pharmaceutical ingredient (API) from the laboratory to clinical trials and commercial manufacturing.

Pharmaceutical and biotech companies face increasing pressure to deliver safe, effective, and cost-efficient drugs faster than ever. As a result, rigorous route scouting has become a critical de-risking step in API development, helping teams identify scalable, cost-effective, and robust synthetic pathways early in the process.

This blog explores when route scouting is most critical and outlines a structured approach to executing it—ensuring the selected synthetic route is phase-appropriate, fit for purpose, and ready for large-scale pharmaceutical manufacturing.

What is route scouting in API development?

Route scouting in API development is the process of identifying, evaluating, and selecting the most efficient and scalable synthetic pathway for manufacturing a pharmaceutical compound. It plays a key role in reducing risk, controlling costs, and enabling successful process scale-up.

When is route scouting important in API development?

Route scouting is not a one-time activity—it is a continuous process that evolves throughout the API development lifecycle. Its importance increases at several key stages:

Early discovery phase

At the outset, when chemists identify molecules with therapeutic potential, route scouting helps establish a feasible synthetic pathway quickly. The focus at this stage is accessibility rather than optimization—ensuring the compound can be produced in sufficient quantity and purity for initial biological testing.

Even at this early stage, evaluating alternative synthetic routes is valuable. It can reveal pathways that are more suitable for future scale-up or provide improved impurity control.

Pre-clinical and clinical phase transitions

As an API progresses into pre-clinical and clinical development, demand for material increases and requirements for purity, safety, and reproducibility become more stringent.

Route scouting becomes essential to ensure the process can meet these demands. For example, a route that performs well at small scale may present challenges during scale-up, such as hazardous byproduct formation or reliance on costly or unavailable raw materials.

Identifying and addressing these risks early helps avoid delays and costly redevelopment. At this stage, route scouting must also consider Good Manufacturing Practice (GMP) requirements and broader regulatory expectations.

Late-stage development and commercial manufacturing

As an API approaches late-stage clinical trials and commercialization, route scouting shifts focus toward scalability, cost-efficiency, and sustainability.

A route that is suitable for clinical supply may not be viable for commercial manufacturing. Factors such as raw material availability, energy consumption, waste generation, and production cycle times become critical.

At this stage, route scouting aims to define a synthetic pathway that can be reliably operated at scale while maintaining product quality, regulatory compliance, and economic viability.

Executing route scouting: A structured approach in chemical process development

Successful route scouting in API development requires a systematic, multi-disciplinary approach combining chemistry, process engineering, and strategic planning.

1. Define objectives and requirements

The first step is to clearly define project goals and constraints. This includes required API quantity and purity, development timelines, regulatory requirements, and cost targets.

For early-phase development, speed and material availability may be the priority. For commercial manufacturing, scalability, robustness, and cost of goods become critical. Aligning route scouting with these objectives ensures resources are focused on viable solutions.

2. Generate and evaluate synthetic routes

Multiple potential synthetic routes should be identified using scientific literature, patent databases, and internal expertise.

Each route should be evaluated against key criteria:

• Chemical feasibility: Robustness of the reaction chemistry.
• Material availability: Cost and supply of starting materials and reagents.
• Safety and environmental impact: Hazardous reagents and waste profile.
• Scalability: Suitability for process scale-up.
• Impurity control: Ability to manage impurities, including genotoxic impurities.
• Cost of goods (COG): Including materials, labor, and energy.

Using a scoring system or decision matrix enables objective comparison and prioritization of the most promising routes.

3. Conduct experimental validation

Shortlisted routes are then validated through experimental studies at small scale. This stage focuses on confirming feasibility, optimizing reaction conditions, and assessing product quality.

Key parameters include yield, selectivity, reaction time, temperature, and ease of isolation and purification. Robustness testing is also critical to ensure reproducibility under variable conditions.

This step is essential for identifying risks before scale-up and ensuring consistent performance during clinical and commercial manufacturing.

4. Optimize the selected route

Once a preferred route is identified, optimization begins. This includes refining reaction conditions, selecting appropriate reagents and solvents, and improving purification processes.

Process engineering principles are applied to ensure the route is scalable, safe, and efficient. Options such as continuous processing may be explored to enhance productivity and reduce manufacturing timelines.

Scale-up is typically performed in stages, starting with pilot-scale studies to identify potential issues before full commercial production. Collaboration with manufacturing partners ensures compatibility with facility capabilities.

5. Assess regulatory compliance

Regulatory considerations must be integrated throughout route scouting and process optimization.

This includes compliance with GMP standards and alignment with regulatory agencies such as the FDA and EMA. Comprehensive documentation is essential—covering experimental data, process parameters, and impurity profiles—to support regulatory submissions and inspections.

Early engagement with regulators can help identify potential issues and streamline approval processes.

Key benefits of route scouting in API development

• Reduces scale-up and manufacturing risk.
• Improves cost efficiency and process robustness.
• Enhances impurity control and product quality.
• Supports regulatory compliance.
• Enables efficient transition to commercial manufacturing.

Conclusion

Route scouting is a critical component of chemical process development and plays a central role in successful API development. By applying it strategically across the development lifecycle, organizations can identify synthetic routes that are scalable, cost-effective, and fit for purpose.

A structured, multi-disciplinary approach to route scouting reduces risk, accelerates development timelines, and supports the delivery of high-quality medicines to patients.

As the pharmaceutical industry continues to evolve, route scouting will remain a key enabler of innovation, efficiency, and successful commercial manufacturing.

Don’t miss the next blog in this series:

Getting analytical data to help choose the right molecule: Understanding the physical characteristics of your molecule and developing robust analytical methods to support route and candidate selection.